| Serial Number | 99580399 |
| Word Mark | VIVARA |
| Filing Date | Tuesday, January 6, 2026 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, March 4, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the word "VIVARA" in a stylized font. Above the word "VIVARA", in a semicircle, are lines of differing lengths. |
| Goods and Services | Vitamin A preparations; Vitamin supplements; Vitamin tablets |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 6, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, December 9, 2025 |
| First Use In Commerce Date | Tuesday, December 9, 2025 |
| Party Name | ALFASIGMA S.P.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 09 - Joint Stock Company |
| Address | BOLOGNA 40133 IT |
| Event Date | Event Description |
| Tuesday, January 6, 2026 | NEW APPLICATION ENTERED |
| Tuesday, January 6, 2026 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, February 25, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 25, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, February 26, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, March 4, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 4, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 4, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |